CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome
D Lahiri, B Seixas-Lima, C Roncero… - Frontiers in …, 2024 - frontiersin.org
Introduction With the advent of anti-β-amyloid therapies, clinical distinction between Aβ+ and
Aβ− in cognitive impairment is becoming increasingly important for stratifying referral and …
Aβ− in cognitive impairment is becoming increasingly important for stratifying referral and …
[PDF][PDF] Serum and Cerebrospinal Fluid Biomarkers in Diagnosis of Dementia
D Lahiri - researchgate.net
Imaging and fluid biomarkers are increasingly being used in clinical practice to diagnose
Alzheimer's disease. These biomarkers can detect the presence of amyloid-beta, tau and …
Alzheimer's disease. These biomarkers can detect the presence of amyloid-beta, tau and …